Currently, there are 11.37M common shares owned by the public and among those 10.96M shares have been available to trade.
The company’s stock has a 5-day price change of 68.94% and -25.68% over the past three months. TRIB shares are trading 54.51% year to date (YTD), with the 12-month market performance down to -32.00% lower. It has a 12-month low price of $0.74 and touched a high of $3.55 over the same period. TRIB has an average intraday trading volume of 172.86K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 56.39%, 39.05%, and -22.53% respectively.
Institutional ownership of Trinity Biotech Plc ADR (NASDAQ: TRIB) shares accounts for 23.86% of the company’s 11.37M shares outstanding.
It has a market capitalization of $15.46M and a beta (3y monthly) value of 1.02. The earnings-per-share (ttm) stands at -$2.26. Price movements for the stock have been influenced by the stock’s volatility, which stands at 14.44% over the week and 11.16% over the month.
Analysts forecast that Trinity Biotech Plc ADR (TRIB) will achieve an EPS of -0.3 for the current quarter, -0.28 for the next quarter and -0.9 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.3 while analysts give the company a high EPS estimate of -0.3. Earnings per share for the fiscal year are expected to increase by 63.87%, and 48.28% over the next financial year.
ROTH Capital was of a view on July 29, 2015 that the stock is Buy, while Roth Capital gave the stock Buy rating on July 22, 2008, issuing a price target of $7- $6. Roth Capital on their part issued Buy rating on March 17, 2008.
